Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Identification of health risk behaviours among adolescent refugees resettling in Western Australia

We aim to identify health risk behaviours among adolescent refugees resettling in WA and assess the feasibility of using a standardised questionnaire.

Innate immunity in human newborn infants: prematurity means more than immaturity

Neonates, particularly those born prematurely, are exquisitely vulnerable to life-threatening infections. This increased susceptibility to infection...

Every Friday: Child Health Research Seminars 2014

Dr Howlett completed her PhD studies in 2009 at the MCRI in Melbourne, where she worked on gastric cancer cell signaling...a

Our History

Discover the origins of The Kids Research Institute Australia, from when it opened in the 90's led by its patron Fiona Stanley up until now, led by Jonathan Carapetis.

Chitra Maharani Saraswati

Chitra is a Research Officer within the Global Disease Modelling team at The Kids Research Institute Australia.

BANDIT trial update

The Children’s Diabetes Centre has had a few inquiries about the new BANDIT trial, based in Melbourne, and whether we are involved. Currently, the trial is only open to people who live in Victoria.The Centre is involved in other Australian studies aiming to better understand diabetes.

Rare Diseases

While individual diseases are rare, as a group, rare diseases are common. Recent estimates suggest that between 3% and 6% of the world’s population are affected by rare disease.

ORIGINS celebrates it’s 10,000th baby, reaching key recruitment milestone

Australia’s biggest longitudinal study following the health and wellbeing of children from their conception through to childhood, has welcomed its 10,000th and final participant.

Effectiveness of 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia and hospitalisation in Eastern Highlands Province, Papua New Guinea: An observational cohort study

Pneumonia is a leading cause of childhood mortality with Streptococcus pneumoniae a major contributor. Pneumococcal conjugate vaccines (PCVs) have been introduced into immunisation programs in many low- to middle-income countries yet there is a paucity of data evaluating the effectiveness in these settings. We assess the effectiveness of 13-valent PCV against hypoxic pneumonia, hospitalisation and other clinical endpoints in children <5 years living in Eastern Highlands Province, Papua New Guinea).

NHMRC funding awarded to support child health research

The Kids Research Institute Australia researchers have been awarded more than $10 million in research funding from the National Health and Medical Research Council (NHMRC).